Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$626M |
| 2 |
Warner Bros
WBD
|
+$447M |
| 3 |
Apple
AAPL
|
+$436M |
| 4 |
RTX Corp
RTX
|
+$434M |
| 5 |
Constellation Brands
STZ
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.13B |
| 2 |
Microsoft
MSFT
|
+$502M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$436M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$415M |
| 5 |
EA
Electronic Arts
EA
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.83% |
| 2 | Technology | 9.75% |
| 3 | Industrials | 9.36% |
| 4 | Consumer Discretionary | 8.52% |
| 5 | Healthcare | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
CALL
NXP Semiconductors
NXPI
$57B
| $2.01M | ﹤0.01% |
10,200
+4,000
| +65% | +$886K |
|
1702
PUT
Li Auto
LI
$11.9B
| $2M | ﹤0.01% |
112,300
-33,500
| -23% | -$585K |
|
1703
Papa John's
PZZA
$765M
| $2M | ﹤0.01% |
61,617
-165,165
| -73% | -$5.73M |
|
1704
CALL
Lyft
LYFT
$6.57B
| $2M | ﹤0.01% |
150,000
-303,500
| -67% | -$4.7M |
|
|
NSRX
1705
Nasus Pharma
NSRX
$48M
| $1.99M | ﹤0.01% |
+898,473
| New | +$4.64M |
|
1706
PUT
lululemon athletica
LULU
$13.1B
| $1.99M | ﹤0.01% |
13,000
+8,900
| +217% | +$1.6M |
|
1707
PUT
Trip.com Group
TCOM
$28.1B
| $1.98M | ﹤0.01% |
39,700
+1,600
| +4% | +$93.3K |
|
1708
PureCycle Technologies
PCT
$1.34B
| $1.98M | ﹤0.01% |
380,858
+244,956
| +180% | +$2.04M |
|
|
KC
1709
Kingsoft Cloud Holdings
KC
$3.17B
| $1.97M | ﹤0.01% |
147,738
+52,188
| +55% | +$682K |
|
1710
NCR Voyix
VYX
$1.27B
| $1.97M | ﹤0.01% |
311,061
+36,928
| +13% | +$326K |
|
1711
CALL
SAP
SAP
$255B
| $1.97M | ﹤0.01% |
+11,500
| New | +$2.37M |
|
1712
Personalis
PSNL
$1.79B
| $1.97M | ﹤0.01% |
+308,696
| New | +$2.61M |
|
1713
Chord Energy
CHRD
$7.99B
| $1.96M | ﹤0.01% |
13,814
+3,761
| +37% | +$410K |
|
|
NNE
1714
Nano Nuclear Energy
NNE
$1.03B
| $1.96M | ﹤0.01% |
95,817
-141,446
| -60% | -$3.86M |
|
1715
Huntington Ingalls Industries
HII
$11.7B
| $1.95M | ﹤0.01% |
5,144
-56,751
| -92% | -$23.4M |
|
1716
CALL
Merck
MRK
$369B
| $1.95M | ﹤0.01% |
16,200
+2,300
| +17% | +$266K |
|
1717
Gossamer Bio
GOSS
$83.2M
| $1.95M | ﹤0.01% |
5,922,298
+4,405,607
| +290% | +$6.92M |
|
1718
PUT
Celsius Holdings
CELH
$8.35B
| $1.94M | ﹤0.01% |
54,700
-44,300
| -45% | -$2.1M |
|
|
PCAPU
1719
ProCap Acquisition Corp Unit
PCAPU
$214M
| $1.94M | ﹤0.01% |
189,473
| – | – |
|
1720
CALL
Johnson & Johnson
JNJ
$640B
| $1.93M | ﹤0.01% |
7,900
-266,000
| -97% | -$62M |
|
1721
Molson Coors Class B
TAP
$7.77B
| $1.92M | ﹤0.01% |
44,623
+8,526
| +24% | +$405K |
|
1722
iBio
IBIO
$69.5M
| $1.92M | ﹤0.01% |
1,010,955
-85,224
| -8% | -$198K |
|
1723
PUT
FIGS
FIGS
$2.51B
| $1.92M | ﹤0.01% |
+130,000
| New | +$1.67M |
|
1724
Matador Resources
MTDR
$7.02B
| $1.91M | ﹤0.01% |
30,310
-522,546
| -95% | -$26.2M |
|
1725
RadNet
RDNT
$5.93B
| $1.91M | ﹤0.01% |
34,246
-159,952
| -82% | -$10.9M |
|
Similar funds
Dmitry Balyasny's Q1 2026 Portfolio in Review
As of Q1 2026, Dmitry Balyasny held 3,716 positions worth $77.1B, down 2.1% from $78.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dmitry Balyasny withdrew a net $3.87B in Q1 2026, closing 911 positions and reducing 1,056 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.13B position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 38% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in Silicon Laboratories worth $257M.
- Dmitry Balyasny's largest Q1 2026 buy was Silicon Laboratories: 1,233,893 shares worth $257M.
- Dmitry Balyasny added most to Meta Platforms (Facebook) in Q1 2026, an estimated $626M increase.
- Dmitry Balyasny's biggest Q1 2026 reduction was Microsoft, cutting an estimated $502M.
- Dmitry Balyasny fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.13B.
- Dmitry Balyasny's ten largest holdings make up 17% of its $77.1B portfolio in Q1 2026.
- Dmitry Balyasny opened 704 new positions and closed 911 in Q1 2026.
- Dmitry Balyasny's portfolio value fell 2.1% quarter-over-quarter to $77.1B.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.